LILRA3 Antibody (YA7115)

Cat. No.: HY-P87427: Data Sheet User Guide for Antibodies
FAQs
Technical Support

LILRA3 Antibody (YA7115) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to LILRA3.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

사이즈		재고
50 μL		견적 받기
100 μL		견적 받기

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

WB: Western Blot;
IHC-P: Immunohistochemistry-Paraffin;
IHC-F: Immunohistochemistry-Frozen;
ICC/IF: Immunocytochemistry/Immunofluorescence;
IF-Tissue: Immunofluorescence-Tissue;
mIHC: Multiplex Immunohistochemical;
IP: Immunoprecipitation;
ChIP: Chromatin Immunoprecipitation;
FC: Flow Cytometry;
ELISA: Enzyme Linked Immunosorbent Assay

Product Detail
Background
제품 설명

제품 설명

LILRA3 Antibody (YA7115) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to LILRA3.

Host

Mouse

Clonality

Monoclonal

분자량

Predicted band size: 47.5kDa;

Species Reactivity

Human

SwissProt ID

Q8N6C8

Immunogen

Purified recombinant fragment of human LILRA3 (AA: 24-168) expressed in E. Coli.

Application &
Dilution Ratio

Application	Dilution Ratio
FC FC: Flow Cytometry	1:200-1:400
ELISA ELISA: Enzyme Linked Immunosorbent Assay	1:10000

Sensitivity	Endogenous	Purity	affinity purified.
Conjugation	Non-conjugated	Modification	Unmodified
Isotype	IgG1

Appearance

Liquid

Formulation

Supplied in PBS with 0.05% sodium azide

Storage & Stability

Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

선적

Shipping with blue ice.

Background

Function：Acts as a soluble receptor for class I MHC antigens. Binds both classical and non-classical HLA class I molecules but with reduced affinities compared to LILRB1 or LILRB2. Binds with high affinity to the surface of monocytes, leading to abolish LPS-induced TNF-alpha production by monocytes

Subcellular Localization：Secreted

Expression：
Tissue_Specificity: Detected in B-cells, and at lower levels in natural killer (NK) cells. Detected in peripheral blood monocytes and lung

Isoforms & Post-Translational Modification：Q8N6C8 has three isomers: Q8N6C8-1: 47472 Da (predicted); Q8N6C8-2: 40357 Da (predicted); Q8N6C8-3: 49187 Da (predicted).
N-glycosylation is required for ligand binding

Database

SwissProt: SwissProt: Q8N6C8

각종 서류

User Guide for Antibodies (1077 KB)